8018-0731 Screening compound: 4-(1H-1,2,3,4-tetraazol-1-yl)-N~1~-(4,5,6,7-tetrahydro-1-benzothiophen-3-ylmethyl)-1-benzenesulfonamide

8018-0731 Screening compound: 4-(1H-1,2,3,4-tetraazol-1-yl)-N~1~-(4,5,6,7-tetrahydro-1-benzothiophen-3-ylmethyl)-1-benzenesulfonamide
8018-0731 Screening compound: 4-(1H-1,2,3,4-tetraazol-1-yl)-N~1~-(4,5,6,7-tetrahydro-1-benzothiophen-3-ylmethyl)-1-benzenesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 8018-0731
4-(1H-1,2,3,4-tetraazol-1-yl)-N~1~-(4,5,6,7-tetrahydro-1-benzothiophen-3-ylmethyl)-1-benzenesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8018-0731

Molecular Formula

C16H17N5O2S2 (C16 H17 N5 O2 S2)

Compound Name

4-(1H-1,2,3,4-tetraazol-1-yl)-N~1~-(4,5,6,7-tetrahydro-1-benzothiophen-3-ylmethyl)-1-benzenesulfonamide

IUPAC name

N-[(4567-tetrahydro-1-benzothiophen-3-yl)methyl]-4-(1H-1234-tetrazol-1-yl)benzene-1-sulfonamide

SMILES

O=S(c(cc1)ccc1-n1nnnc1)(NCc1csc2c1CCCC2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

375.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.222

Distribution Coefficient, logD

3.221

Water Solubility, LogSw

-3.60

Polar Surface Area

82.701

Acid Dissociation Constant (pKa)

10.46

Base Dissociation Constant (pKb)

-2.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.25

8018-0731 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 8018-0731 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8018-0731?
Check Price and Availability of 8018-0731, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8018-0731 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8018-0731
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8018-0731
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8018-0731 available by request